Experimental and clinical data suggest the presence of multiple types of adenosine diphosphate (ADP) receptors, one coupled to ligand-gated cation channels (P 2X ) and others coupled to G-proteincoupled (P 2Y ) receptors. This report identifies cDNA for a structurally altered P 2X1 -like receptor in megakaryocytic cell lines (Dami and CMK 11-5) and platelets that, when transfected into nonresponsive 1321 cells, confers a specific sensitivity to ADP with the pharmacologic rank order of ADP > > ATP > > > ␣,␤-methylene-ATP as measured by Ca ؉؉ influx. This receptor (P 2X1del ) contains a deletion of 17 amino acids (PALLREAENFTLFIKNS) that includes an NFT consensus sequence for N-linked glycosylation. Glycosylated forms of the P 2X1del and P 2X1wt receptors were indistinguishable electrophoretically by Western blot or by immunoprecipitation using available antihuman and antirat antibodies. These results indicate that the expression of the P 2X1del receptor results in an influx of Ca ؉؉ induced by ADP. Expression of P 2X1del receptor homomeric subunits is sufficient to express a receptor preferentially activated by ADP and suggests that this altered form, alone or in combination with P 2X1wt receptors, is a component of an ADP-activated ion channel. ( 
Introduction
Adenosine diphosphate (ADP) is known to play a key role in the development and extension of arterial thrombosis, the deposition of platelets onto collagen under flow conditions, collagen-induced aggregation, and the stabilization of thrombin-induced human platelet aggregates independent of fibrinogen binding to GPIIb/ IIIa, and it plays an important role in irreversible aggregation induced by PAR-1. [1] [2] [3] [4] [5] Reduced thrombus formation is observed when platelets from patients with storage pool deficiency are exposed to vascular subendothelium and when removal of ADP from blood-perfusing damaged arteries results in increased bleeding times. 4, 6 Platelet aggregation is impaired in 2 patients with a congenital defect of platelet response to ADP, 1, 7 further demonstrating that released ADP plays an important role in platelet activation though the mechanism of activation has not been elucidated. Significantly, inhibitors of ADP-induced aggregation are effective antithrombotic drugs. 8, 9 Two subclasses of purinergic receptors have been described: P 2Y metabotropic receptors coupled to heterotrimeric G-proteins and P 2X ion channel receptors. Evidence has been provided for 2 distinct G-protein-coupled receptors in human platelets, one coupled to the inhibition of stimulated adenylate cyclase (the P 2YAC receptor) and the other a P 2Y1 receptor (the P2T PLC receptor) coupled to the activation of phospholipase C. [10] [11] [12] The P2T AC (or P2Y AC ) receptor, now termed the P2Y 12 receptor, has been recently identified. 13 AR-C69096, an adenosine triphosphate (ATP) analog, is a selective inhibitor of ADP-induced platelet aggregation that antagonizes ADP-induced activation through the P2Y 12 receptor. 14 ATP is a competitive inhibitor of ADP-induced aggregation and adenylyl cyclase inhibition. 15 A model for the activation of platelets by ADP involving a 3-receptor model has been proposed [10] [11] [12] and is a refinement of the model 16 involving rapid calcium influx mediated by a receptor-operated Ca ϩϩ channel, whereas adenylyl cyclase inhibition and intracellular Ca ϩϩ mobilization are mediated by a single P 2Y receptor involving multiple G proteins. The crucial role of heterotrimeric G proteins has been demonstrated by using platelets from P 2Y1 -null mice 17, 18 and in G ␣q -deficient mice, the latter of which are deficient, in part, in their activation by ADP 19 although partial aggregation and potentiation with other agonists are retained. 20 In platelets, the presence of P 2X1 receptors and mRNA has been reported using polymerase chain reaction (PCR), Fura-2-measured Ca ϩϩ influx, protein blotting, [21] [22] [23] [24] [25] [26] and activation by ␣,␤-methylene ATP, a selective activator of P 2X1 receptors. 22, 25, 26 P 2X1 receptors demonstrate rapid and transient activation by ATP. 27, 28 ADPinduced Ca ϩϩ mobilization is a biphasic process 29 implying multiple receptors and pathways. It is unclear whether the P 2X1 ion channel receptor in platelets is required or sufficient for cellular activation or whether multiple subunits of P 2X -like receptors are responsible for Ca ϩϩ influx. Recent data suggest that although P 2X1 receptors play functional roles in human platelets, 30 it has been suggested that ADP is not an agonist at P 2X1wt receptors, 31 in contrast to its activation by ATP.
We have previously demonstrated that ADP and ADP-␣-S mobilize Ca ϩϩ in Xenopus laevis oocytes injected with mRNA derived from megakaryocytic CMK 11-5 cells, and this mobilization is specifically blocked by ATP and ATP-␣-S, as expected for a platelet-type receptor. 32 We have now used a homology PCR approach based on cDNA sequences of previously identified ion-gated P 2X receptors to identify purinergic receptors on platelets, megakaryocytic CMK 11-5 cells, and megakaryoblastic Dami and CMK cells.
Materials and methods

Reagents and solutions
Carbachol, ADP, and ATP were purchased from Sigma Chemical (St Louis, MO); nucleotides were purified to homogeneity using ion exchange chromatography with triethyl ammonium bicarbonate buffer. Pyridoxalphosphate-6-azophenyl-2Ј,4Ј-disulfonic acid (PPADS), suramin, ␣,␤-methylene-ATP, 2-methylthio-ADP, and ␤,␥-methylene-ATP were from Research Biochemicals (Natick, MA). Fura-2 acetoxymethylester and SK&F 96365 were from Calbiochem (San Diego, CA). Geneticin and all tissue culture reagents were from Gibco-BRL (Gaithersburg, MD).
RNA isolation and polymerase chain reaction amplification
Three bands with P 2X1 sequence homology were identified using PCR amplification (expected product size, 450 bp) based on an internal primer pair (5Ј sense 603 ATCCGCACGGGCAAGTGTGT and 3Ј antisense, 1059 GC-CTGGCAAACCTGAAGTTG) corresponding to the human bladder wildtype P 2X1 receptor (accession number, X83688). Total RNA was isolated (TRIzol; Gibco-BRL) from CMK 11-5 and CMK cells, kindly provided by Dr A. Sato (Mochida Pharmaceutical, Mochida, Japan), and from platelets (American Red Cross) and Dami cells (ATCC, Rockville, MD). Preparations of platelet RNA 33 were found to be negative for TAPA-1, a widely expressed white blood cell antigen using PCR primers (5Ј-ACAAGGAC-CAGATCGCCAAGG-3Ј (sense) and 5Ј-GTACAGCTTCCCGGAGAA-GAG-3Ј (antisense) as described. 26 Ficoll-purified neutrophils from whole human blood and Jurkat cells (ATCC) revealed a positive PCR band at 266 bp (data not shown). In brief, platelet-rich plasma was centrifuged 3 times at 800g, and the upper two-thirds volume was removed for further processing. Multiple centrifugation steps and the removal of the upper plasma fraction reduced the presence of white blood cells to undetectable levels by PCR analysis. The Dami cells express epitopes for CD42a, CD42b, and CD42d (data not shown) measured by FACS analysis, indicating identity with the original cell line. 34, 35 Cell lines were maintained in RPMI 1640 media containing 10% fetal bovine serum without penicillin-streptomycin. Reverse transcription reactions (20 L) consisted of RNA (9 g), dNTP, RNAase inhibitor, random primer, oligo-dT, and MuLV reverse transcriptase. RNA was heated to 65°C for 10 minutes and allowed to cool to 4°C. Reagents were added, and the reaction (45 minutes at 42°C) was followed by a 10-minute room temperature hold. Samples were heated to 100°C for 5 minutes, cooled to 4°C, then used for PCR reactions or stored at Ϫ20°C. First-strand cDNA synthesis used 500 ng total RNA and Superscript II (Gibco-BRL). PCR reactions, performed in 40 L, consisted of cDNA, 0.5 M PCR primers, 2.0 mM Mg 2ϩ , 200 M dNTP, and 5 U Taq DNA polymerase. The PCR thermal cycle consisted of 2 minutes at 94°C and 40 cycles of 30 seconds at 94°C, 60 seconds at 55 to 60°C, and 60 seconds at 72°C. To amplify the entire open reading frame of both cDNAs, PCR was carried out with these identical conditions except that 35 cycles were used for the amplification and a 5-minute elongation step was included to allow for the completion of full-length cDNA. PCR reactions used a 5Ј sense primer, TAA [GGATCC] CCACCATGGACGGCGGTTCCAG that included a Kozak sequence and a BamHI site (brackets), and a 3Ј antisense primer CA [TCTAGA] TCAGGATGTCCTCATGTT that included an XbaI site (brackets). Two BamHI-XbaI fragments, corresponding to nucleotides 1 to 1199 of the human bladder wild-type P 2X1 clone and one reduced by 51 bp (full-length P 2X1del clone), were directionally cloned into pcDNA3 (Invitrogen, Carlsbad, CA) and transformed into TOP10FЈ or INVFЈ cells grown in LB agar.
Specific amplification of the P 2X1del cDNA from platelets
To selectively amplify P 2X1del cDNA, 2 primers were used-sense primer 711 ACATCCCGCGC-ATCAGCT (the dashes indicate where the 51-bpdeleted cDNA sequence would be observed in the P 2X1wt receptor) and the antisense primer 1082 GCCTGGCAAACCTGAAGTTG. The first primer contains a 5Ј 11-base sequence and a 3Ј 7-base sequence that span the deleted 51-base sequence and are found only in the P 2X1del cDNA. An expected PCR amplicon is calculated to measure 371 bp ( Figure 1C ). This PCR primer pair was used to amplify a 371 bp band from cDNA isolated from platelets and from a 400-bp partial P 2X1del cDNA sequence (amplified using the primers described in the preceding paragraph) inserted into the pCRII plasmid. For high-stringency conditions, 35 PCR cycles using the annealing temperature of 60°C were performed. 35 S-methionine-labeled receptors were prepared from the P 2X1wt and P 2X1del pcDNA3.1 plasmids using a coupled TnT (Promega, Madison, WI) transcription-translation (reaction time, 75 minutes) and were immunoprecipitated with the MAP anti-P 2X1 antibody (described below) or subjected to 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and autoradiography. Both glycosylated and nonglycosylated receptor forms generated from both plasmids using the TnT (Promega) system were immunoprecipitated with the anti-hP 2X1 antibody, which is directed against a common GKAKRK peptide sequence (data not shown).
In vitro transcription-translation
Preparation of anti-human P 2X1 receptor antibody
An octavalent core matrix of a multiple antigenic peptide (human, [h]) was used to generate an anti-GKAKRKAQGIRTGF polyclonal antibody (antihP 2X1 pAb) and was used directly for injection as the immunogen. Analysis of the purity of the peptide by reversed phase high-performance liquid chromatography confirmed the stoichiometry of the composite amino acids. Rabbits (male New Zealand White) were bled (preinjection sample) before intradermal injections of 200 g emulsified MAP antigen in 600 L PBS mixed with 600 L Freund complete adjuvant. After booster injections at 14, 28, 56, and 84 days, total IgG was isolated using protein G-Sepharose columns, and IgG was eluted with 0.1 M glycine, pH 2.5, and 0.15 M NaCl and immediately neutralized with 1.0 M Tris, pH 8.0. Before use, antibodies were dialyzed against PBS.
Immunoprecipitation and Western blot analysis of P 2X receptors
For immunoprecipitation experiments, surface-biotinylated (20 M sulfo-NHS-biotin-SO 3 (Pierce, Rockford, IL) 1321 cells transfected with either the P 2X1wt or P 2X1del receptors were solubilized in RIPA buffer (0.05 M Tris-HCl, pH 7.4, 150 mM NaCl, 1.0% Nonidet P-40, 0.25% deoxycholate, 1 mM EDTA, 1 mM EGTA, 1 mM PMSF, 200 mM Na 3 VO 4 , and 1 g/mL each of aprotonin, leupeptin, and pepstatin). Native Dami, CMK 11-5, or CMK cells were treated similarly. Surface-labeled receptors were immunoprecipitated with the anti-P 2X1 pAb (5 g total IgG) and complexed with protein A/G beads, and supernatants were analyzed under reducing conditions on 7% SDS-PAGE gels. After overnight electrophoretic transfer to nitrocellulose (30 mA, 18 hours; 300 mA, 2-3 hours), surface-labeled and precipitated antigens were detected by a streptavidin-horseradish peroxidase (1:20 000 dilution) enhanced chemiluminescence method. For Western blotting experiments, proteins on nitrocellulose membranes were recognized with 2.5 g/mL anti-C-terminus anti-P 2X1 receptor antibody. 21 Bound antibody was visualized by a goat-antirabbit-HRP-conjugated secondary antibody and the enhanced chemiluminescence method. Protein molecular weights were compared to Rainbow (Amersham, Arlington Heights, IL) prestained markers.
Flow cytometry
Flow cytometry 36 confirmed the surface expression of a P 2X1 receptor(s) using both the anti-hP 2X1 antibody (described above) and an anti-rat P 2X1 antibody (kindly provided by Dr Julian Barden, University of Sydney, Australia) directed against an identical amino acid sequence in the human receptor. Both Dami cells and CMK 11-5 cells demonstrated binding of both antibodies (data not shown). 
Cell transfection
Astrocytoma cells (1321N1; kindly provided by Dr Myron Toews, University of Nebraska) were maintained in a low-glucose (1 g/L) Dulbecco modified Eagle medium (DMEM) buffer (Gibco-BRL) supplemented with 3.7 g NaHCO 3 /L at 37°C and 5% CO 2 . Transfection reactions in the presence of Opti-MEM (Gibco-BRL) used 2 g circular plasmid DNA and 10 L Lipofectamine (Gibco-BRL) for 12 hours at 37°C. Complete medium was added for 24 hours. Cells were then removed with trypsin-EDTA for replating onto 100-mm Petri dishes (Falcon 3803), and 600 g/mL Geneticin (G418) was added for selection. After selection for 12 to 30 days, individual colonies of cells were isolated using cloning cylinders. Stably transfected 1321 cells, maintained in 240 g/mL G418, were grown to 100% confluency for 2 to 5 days on coverslips coated with 0.2% gelatin (Bio-Rad, Hercules, CA) dissolved in PBS. Four P 2X1wt clones (W1, W2, W3, W4) and 5 P 2X1del clones (DL1, DL2, DL3, DL4, DL5) were further characterized in this report.
Intracellular Ca ؉؉ influx
For Ca ϩϩ influx studies, adherent cells on coverslips were incubated for 30 to 60 minutes at 37°C in 1 mL DMEM media with 2.5 M Fura-2 acetoxymethyl ester dissolved in dimethyl sulfoxide before a single exchange of DMEM-Tyrode-HEPES buffer as previously described. 21, 22, 24, 25, 37, 38 Ca ϩϩ influx was measured with single monolayers (0.6 ϫ 1.1 cm) of adherent nontransfected or transfected 1321 cells in a Time Drive program with a PerkinElmer LS50B fluorometer ( ex 340 nm and em 510 nm, slit widths 10 nm in matched quartz cuvettes). This program is approximately 10 times more sensitive than the Intracellular Biochemistry program (Perkin Elmer, Buckinghamshire, England) and has been validated in work with the P 2X1 receptor. 21, 22, [24] [25] [26] Ca ϩϩ influx is shown in arbitrary linear units of Fura-2 emission measured at 510 nm. Fura-2-labeled cells in 1.2 mL Tyrode-HEPES, pH 7.4 buffer were incubated with 2 mM Ca ϩϩ before the addition of reagents under high-stirring conditions (approximately 1000 rpm). Of importance, there was no Ca ϩϩ influx to ADP or ATP in the absence of exogenous Ca ϩϩ or using nontransfected 1321 cells, demonstrating that Ca ϩϩ influx with transfected cells results only from the activation of expressed receptors. Purinergic receptor inhibitors were incubated with cells for 1 minute before the addition of nucleotides. Results show qualitative comparisons between P 2X1wt and P 2X1del receptors and the concentrations of nucleotides used to activate the receptors. In all experiments (200-240 seconds), nucleotide agonists were sequentially added, and then 50 M carbachol, a muscarinic agonist, was added to elicit a positive standard response from its endogenous receptor. The addition of digitonin, as used in previous experiments 32,36-38 to PCR amplification using P2X1-derived ORF primers (S or 5Ј sense 603 ATCCGCACGGGCAAGTGTGT and AS or 3Ј antisense, 1059 GCCTGGCAAACCTGAAGTTG) to amplify a partial P2X sequence revealed the homologous wild-type P2X1 receptor and an in-frame 51-bp deletion clone (P2X1del). Lines above the figure represent the expected 450-bp P2X1wt sequence and the identified 400-bp P2X1del sequence. Sequence numbering is relative to a P2X1 receptor (accession number, X83688). ORF primers include 5Ј BamHI and 3Ј XbaI sites facilitating subcloning into pcDNA3.1 and subsequent transfection into 1321 cells. Within the 51-bp deletion variant is a glycosylation site indicated in bold, underlined type. The 51-bp deleted DNA sequence is shown with its deduced amino acid sequence relative to its location with the 2 transmembrane regions (TM1 and TM2), the location of 2 proposed extracellular cysteine loops, and a pore site (H1). GKAKRK is an amino acid antibody determinant deduced by the PCgene program and used for antibody production. (B) Comparison of PCR amplification products using CMK 11-5 cells and platelets. Primers (S and AS) were used to amplify a partial sequence in the extracellular portion of the P2X1wt receptor. Besides the expected amplicon of 450 bp, a band of 400 bp was observed. PCR results with CMK 11-5-derived mRNA showed approximately equal or greater amplification of the 450-bp band (wild-type P2X1 cDNA) than the 400-bp band (deletion P2X1 cDNA) (compare lanes 1-4), whereas platelets (lane 5) demonstrated a greater proportion of the 400-bp amplicon. Varying the annealing temperature for the PCR reaction at 50°C, 55°C, or 60°C (lanes 1-3, respectively) did not vary the intensity of the bands. PCR products were subcloned into pCRII and were sequenced for confirmation. (C). Selective PCR amplification of the P2X1del receptor in platelets. Two primers (sense primer (S2) 688 ACATCCCGCGCATCAGCT and antisense primer (AS1) 1082 GCCTGGCAAACCTGAAGTTG) were used to selectively amplify platelet P2X1del cDNA (note that AS and AS1 primers are identical). An 11-base sequence (ACATCCCGCGC) and a 7-base sequence (ATCAGCT) span the 51-bp deletion sequence and are found only in the P2X1del cDNA. (D) Agarose gel of PCR amplicon. Using the PCR primer pair (S2 and AS1), an approximately 371-bp PCR band from both cDNA isolated from platelets (lane 1) and from a 400-bp partial P2X1del cDNA sequence inserted into the pcDNA3.1 plasmid (lane 2) are amplified. PCR reactions used an annealing temperature of 60°C. Although an expected PCR reaction would result in 2 PCR products using the primers designated S1 and AS1-one of 451 bp for the P2X1wt receptor and one of 400 bp for the P2X1del receptor (see Figure 1B )-a single PCR product of approximately 371 bp using primers S2 and AS1 directly indicates the presence of the P2X1del receptor. Lane 3 is a PCR reaction with the S2 and AS1 primers with a pcDNA3.1 plasmid containing irrelevant DNA.
permeabilize cells to obtain maximal Ca ϩϩ concentrations for calibration curves, removed adherent cells from the coverslips and therefore maximum and minimum Ca ϩϩ concentrations were not determined.
This Ca ϩϩ influx method measures the total cumulative Ca ϩϩ signal for the entire population of adherent cells, not for an individual cell as in the electrophysiological method. Although the method is incapable of resolving the kinetics of influx of Ca ϩϩ through the opening and closing of individual receptor gates, the method is capable of measuring the cumulative signals from many adherent activated cells. Our expectations are that the action potentials generated by the Fura-2 method and the electrophysiological method would be different because Fura-2 measures the mass action of Ca ϩϩ influx by averaging the values from many intact cells. Fura-2 is distributed in the cytoplasm and is not localized as the electrophysiological measurements. Therefore, it is expected that the Fura-2 method will be slower in the time-course of activation, and this reflects the slower diffusion of the agonist over the cell surfaces. Because we are using Fura-2 to relate qualitative differences (and are not measuring quantitative kinetic results), this method is valid to measure Ca ϩϩ influx from many cells. In addition, the Fura-2 method has been successfully used and reported for comparative studies of P 2X1 receptors. 21, 22, 25, 26, 30, 31 Traces in Figures 4C and 4D show only the initial activation time of 30 seconds, whereas in other studies, 21, 22, 25, 26 the figures are displayed over 200 to 300 seconds; these different presentations result in significant differences in the appearance of the activation profiles.
Results
PCR amplification of P 2X1 homologs
PCR amplification was carried out using mRNA from Dami cells, CMK, CMK 11-5 cells, and platelets in reactions containing nondegenerate primers based on a human urinary bladder P 2X1 receptor (accession number, X83688). 27 Primers (5Ј sense 603 ATC-CGCACGGGCAAGTGTGT and 3Ј antisense 1059 GCCTG-GCAAACCTGAAGTTG) were selected to amplify approximately one third of the 1200-bp open-reading frame (ORF) in the extracellular portion of the P 2X1 wild-type (P 2X1wt ) receptor (450 bp) and, in addition, yielded a band of 400 bp. Subcloning and sequencing ( Figure 1A ) revealed these 2 related clones 27, 28 and, most important, directly demonstrated the presence of multiple mRNAs for these receptors in these cells ( Figure 1B) . The 400-bp band (designated the P 2X1 deletion clone or P 2X1del ) has a 51-bp in-frame deletion and would correspond to the deletion of 17 amino acids PALLREAENFTLFIKNS (calculated MWt, 1961) in the extracellular domain. This region is flanked by 5Ј and 3Ј ORF sequences identical to the P 2X1wt receptor ( Figure 1A ). PCR amplification of CMK 11-5-derived mRNA (and mRNA from Dami cells; data not shown) showed equal or slightly greater amplification of the 450-bp (P 2X1wt clone) than the 400-bp P 2X1del band. In contrast, platelets demonstrated a greater proportion of the P 2X1del 400-bp amplicon ( Figure 1B) with apparent, but reduced, P 2X1wt 450-bp amplicon levels.
Using the primer pair identified in "Materials and methods" ( Figure 1C ), a single band of approximately 350 to 375 bp (expected size, 371 bp) was amplified using platelet cDNA ( Figure  1D, lane 1) or with a pcDNA3.1 plasmid containing a partial 400-bp P 2X1del cDNA ( Figure 1D , lane 2). In the P 2X1wt cDNA, the 11-and 7-base sequences comprising the sense primer ( Figure 1C ) are separated by 51 bases that have been deleted in the P 2X1del cDNA ( Figure 1C) ; therefore, the 11-and 7-base sequences form a linear 18-base sequence for primer annealing only in P 2X1del cDNA.
When pcDNA3.1 plasmids containing the entire ORF of the P 2X1wt and P 2X1del clones were transcribed and translated in vitro, differences were observed in the molecular size of translated protein, whether in the presence of microsomes to effect glycosylation (Figure 2 ; P 2X1wt ϩ, lane 1; P 2X1del ϩ, lane 2) or in their absence (P 2X1wt Ϫ, lane 3; P 2X1del Ϫ, lane 4). Only one type of P 2X1wt or P 2X1del plasmid DNA was observed in each plasmid preparation because only a single translated and glycosylated protein product was observed. This indicated that only homomeric receptor complexes were formed and expressed in the transfected 1321 cells. Both glycosylated and nonglycosylated forms of each receptor were detectable in each preparation, and both forms were immunoprecipitated by the polyclonal antipeptide anti-hP 2X1 antibody (data not shown). . Most important, no apparent size difference was observed between the single protein that was immunoprecipitated from these preparations. These experiments demonstrated the specificity of the antibody receptor interaction (lanes 2, 4, 6, 8, 10, 11). Proteins were not immunoprecipitated using preimmune antisera (lanes 1, 3, 5, 7, 9); these immunoprecipitation results were corroborated using an anti-rat P 2X1 antibody 39 (data not shown). These results are from different SDS-PAGE gels, but chromatography of biotin-labeled P 2X1wt and P 2X1del receptors in adjacent lanes showed no significant differences in size.
P 2X1wt and P 2X1del receptors are equivalent in molecular size
In addition, Western blot analysis with an anti-human P 2X1 polyclonal antibody directed against the C terminus of the human P 2X1 receptor 21 (kindly provided by Drs George Dubyak and Karen Parker, Case Western Reserve University, Cleveland, OH) showed an identically sized 60-kd band comparing Dami cells with P 2X1wt -and P 2X1del -transfected 1321 cells, whereas nontransfected 1321 cells were negative (data not shown). As with the immunoprecipitation experiments (Figure 3 ), no apparent differences were noted in the molecular size of the single blotted protein band.
Figure 2. SDS-PAGE analysis of 35 S-methionine-labeled P2X1wt and P2X1del receptors after transcription and translation reactions. Proteins translated from
P2X1wt and P2X1del plasmid (pcDNA3.1) DNAs were radiolabeled with 35 S-methionine using a coupled transcription-translation (TnT) rabbit reticulocyte system in the presence or absence of microsomes. Note the differences in the apparent molecular sizes for translated proteins between different plasmid constructs, separated by SDS-PAGE, in the presence of microsomes (lanes 1 and 2) or in their absence ( lanes  3 and 4) . Note that each plasmid preparation contains only P2X1wt or P2X1del DNA and that, therefore, only homomeric receptor complexes can be formed. Both ATP and ADP activated Ca ϩϩ influx to comparable levels, as shown in dose-response curves of P 2X1wt -receptor transfectants ( Figure 4A ). In contrast, a direct comparison of dose-response curves using 1321 cells expressing the P 2X1del receptor demonstrated a 10-to 30-fold increased sensitivity of the P 2X1del receptor to ADP when compared to activation by ATP ( Figure 4B ); 2-methylthio-ADP (30 M) caused Ca ϩϩ influx to a similar extent as for ADP (data not shown). The rightward shift in the dose-response curve for the activation by ATP resulted from both the reduced amount of Ca ϩϩ influx and the increased time required to reach peak influx. Differences in the rate of Ca ϩϩ influx between ATP and ADP demonstrated the increased sensitivity of the P 2X1del receptor to activation by ADP and was particularly evident at concentrations as low as 3 M (Figure 4B) .
No activation by ATP is apparent until 3 M or greater ( Figure  4C ), although activation of P 2X1del -transfected cells is apparent at 0.3 and 1 M ADP ( Figure 4D, curves 1 and 2) . A marked delay (relative to ADP) is observed during ATP activation that is only partially reduced by increasing the nucleotide concentration to 10 M ( Figure 4C ) or even 30 M (not shown). These results were observed for 4 P 2X1del clones. Note that these profiles show the first 30 seconds of Ca ϩϩ influx.
Sequential exposure of P 2X1wt receptors (shown for the W1 clone) to nucleotides ( Figure 4E ) demonstrated that the addition of both ATP (30 M) and ADP (30 M) activated Ca ϩϩ influx. In contrast, activation of P 2X1del receptors (shown for the DL4 clone) by ADP (30 M) was not followed by any Ca ϩϩ influx elicited by Figure 4F ). Carbachol (C) was added to confirm Fura-2 labeling of the adherent monolayers.
ATP (30 M) (
P 2X1del receptors are not activated by ␣,␤-methylene-ATP
To compare the ability of ADP and ATP to sequentially activate P 2X1del receptors, stably transfected 1321 cells expressing P 2X1del receptors were labeled with Fura-2 and grown on coverslips designated experiments 1, 2, and 3 ( Figure 5 ). In data expressed as the rate of Ca ϩϩ influx, adherent cells on different coverslips were sequentially exposed (experiment 1) to ADP (30 M, column 1) before ATP (30 M, column 2) or, conversely, in experiment 2, to ATP (30 M, column 3) before ADP (30 M, column 4) ( Figure 5 ). Experiment 3 shows the results of the addition of ␣,␤-methylene-ATP (100 M, column 5) before ADP (30 M, column 6). Data in Figure 5 , expressed as the rate of influx, is summarized for 3 individual P 2X1del receptor clones (designated DL1, DL2, and DL5) expressed in 1321 cells. ADP (30 M) induced a rapid peak of Ca ϩϩ influx (column 1), yet a secondary addition of ATP (30 M) or ADP (30 M) was completely ineffective at causing further Ca ϩϩ influx. Primary exposure to ATP (column 3) acted as a weak agonist, but this maximal activation required an increased time compared to the more rapid peak influx of Ca ϩϩ by ADP ( Figure  4C ). In contrast to the absent secondary activation by ATP after the addition of ADP (column 2), a secondary addition of ADP after the primary addition of ATP (column 4) continued to be effective at causing the influx of a secondary but significantly reduced peak of Ca ϩϩ . In experiment 3 and in contrast to the results observed with the primary addition of ATP (column 3), the primary addition of ␣,␤-methylene-ATP (100 M) was completely ineffective at causing Ca ϩϩ influx (column 5). In addition, this prior exposure of the cells to ␣,␤-methylene-ATP did not affect the Ca ϩϩ influx elicited by 30 M ADP (column 6). 2-Methylthio-ADP at 30 M caused Ca ϩϩ influx with a potency equivalent to that of ADP using the P 2X1del transfected cells (data not shown).
It must be noted that despite the weak activation of the P 2X1del receptor by higher concentrations of ATP, as shown in Figure 4C , the rate of ATP-induced activation (expressed as the peak Ca ϩϩ mobilization measured at 510 nm [arbitrary units] divided by the time required for maximum activation or expressed as U/s) was significantly prolonged compared with activation by ADP ( Figure  4D ). ADP-induced Ca ϩϩ influx is more rapid than ATP-induced Ca ϩϩ influx; the latter requires 2-to 3-fold more time, and this is reflected in rate values only approximately one third of the ADP-induced maximum rate. For example, with the P 2X1del receptor, the activation rate for 30 M ADP (7.2 Ϯ 2.0 U/s) is significantly greater than that observed with 30 M ATP (1.1 Ϯ 0.67 U/s), reflecting both the increased time required for ATP activation and the reduced overall peak of Ca ϩϩ influx ( Figure 5 ). Prior exposure to 30 M ATP decreased the secondary activation of Ca ϩϩ influx by 30 M ADP to 1.3 Ϯ 1.0 U/s, a reduction of 85%. The nonhydrolyzable ATP analog ␣,␤-methylene-ATP, at concentrations to 100 M, was completely ineffective at causing measurable Ca ϩϩ influx ( Figure 5 , column 5), as was ␤,␥-methylene-ATP (data not shown). In addition, both ␣,␤-methylene-ATP (100 M) and ␤,␥-methylene-ATP (100 M) were ineffective at blocking Ca ϩϩ influx induced by 1 M ADP (data not shown) indicating that neither interacts with the expressed receptors.
These quantitative differences are not the result of differences in the surface expression of the transfected receptors, in contrast to results with a P 2X2 receptor, in which densensitization 40 or surface expression 41 is dependent on the extent of glycosylation. In the current study, using equivalent cell numbers, the intensity of the immunoprecipitated band at 67 kd and the Western blotted band at 60 kd were similar, demonstrating that similar levels of P 2X1wt and P 2X1del receptors were surface expressed.
Purinergic receptor antagonists block Ca ؉؉ influx induced by ADP
To compare the pharmacology of Ca ϩϩ mobilization by the P 2X1del receptors, experiments were conducted in the presence of suramin (a P 2 antagonist), PPADS (a P 2X antagonist), or SK&F 96365 (which antagonizes fast, responsive ion channels) 42, 43 (Figure 6 ). Prior exposure of P 2X1del or P 2X1wt -transfected cells to PPADS, suramin, or SK&F 96365-neither of which caused Ca ϩϩ influxresulted in reduced responses to activation by ADP for P 2X1del ( Figure 6 ) and ATP for P 2X1wt (data not shown) receptors. For the P 2X1del receptor, SK&F 96365 at 80 M inhibited Ca ϩϩ influx by 30 M ADP (column 1) by 95% or more ( Figure 6 , column 2), whereas PPADS (at 30 M and 100 M) inhibited 30 M ADP-induced peak Ca ϩϩ influx by 75% and 96% (columns 3 and 4), respectively. Suramin at 100 M inhibited Ca ϩϩ influx by 75% ( Figure 6 , column 5). As with intact platelets, 37 Ca ϩϩ mobilization was inhibited by 30 M ATP-␣-S which, by itself, induced a slow increase in rate of activation, comparable to that for ATP (data not shown). 
Discussion
The current study shows that several megakaryocytic cell lines contain a P 2X1 -like receptor in which there is a deletion of a 17-amino acid extracellular sequence. We have termed this the P 2X1del receptor. Expression of the P 2X1del receptor in 1321 cells confers a selective sensitivity to ADP and 2-methylthioADP, in contrast to expression of the P 2X1wt receptor in which both ATP and ADP induce Ca ϩϩ influx. These pharmacologic changes may reflect conformational changes in the P 2X1del receptor resulting from the loss of the 17-amino acid extracellular sequence normally observed in the P 2X1wt receptor. The loss of the N 708 FT glycosylation site and the amino acid sequence that separates 2 speciesconserved extracellular cysteine-folding domains in the deleted peptide, based on amino acid sequence alignment of 7 known members of the rat P 2X receptor family, 39 may result in these changes. Antagonism of Ca ϩϩ influx (Figure 6 ) demonstrates that the structure of the P 2X1del receptor retains the ability to interact with purinergic receptor inhibitors (PPADS, 44 suramin, 45, 46 or SK&F 96365 42 ), despite structural changes that result in altered pharmacologic responses.
Peptide-sequence alignment of known P 2X2 and P 2X7 receptors also revealed that the deleted PALLREAENFTLFIKNS sequence corresponds to exon 6 and may be a naturally occurring variant of P 2X1 receptors possibly generated by alternative splicing, as observed in the pituitary and cochlea. 47 These conformational changes in the P 2X1del receptor may affect the oligomerization of the receptor subunits, but they do not affect its quantitative expression because P 2X1wt and P 2X1del receptors are expressed in equal amounts in transfected 1321 cells.
Using PCR primers restricted to the 5Ј region of the P 2X1wt receptor, we have identified P 2X1del and P 2X1wt receptor RNA in megakaryocytic cell lines and platelets and showed by DNA sequencing that the latter is identical to the previously described P 2X1wt receptor. 27, 28 These results differ from those previously obtained using PCR primers designed to amplify cDNA corresponding to the entire extracellular domain of the P 2X1wt receptor that indicate the preferential amplification of a P 2X1wt receptor. 26 ATP and ␣,␤-methylene-ATP cause weak, transient activation of Ca ϩϩ mobilization in human platelets, but the relevance of this functional activation is unknown because ATP and ␣,␤-methylene-ATP neither cause platelet aggregation nor alter ADP-induced activation, 21, 22, 25, 31, 48 but there is some evidence that P 2X1 receptors are functionally active. 30 Activation of the P 2X1wt receptor by ATP is in contrast to the P 2X1del receptor, which is activated preferentially by ADP and not by ATP or ␣,␤-methylene-ATP. In addition, we have used a PCR primer with a sequence found only in the P 2X1del receptor to demonstrate directly the presence of P 2X1del receptor cDNA in platelets.
Although it is possible that the P 2X1 ADP receptors expressed on megakaryocytes consist of both P 2X1wt and P 2X1del subunits, it is clear from the current study that expression of the P 2X1del receptor alone in 1321 cells is sufficient to effect sensitive and preferred activation by ADP. The inability of ␣,␤-methylene-ATP to activate P 2X1del receptors at concentrations (100 M) that exceed by 330 times a concentration of ADP (0.3 M), which causes measurable Ca ϩϩ influx, clearly indicates the specificity of the P 2X1del receptor for activation by ADP. The time to effect maximal Ca ϩϩ influx on the order of several seconds (peak Ca ϩϩ influx, approximately 10-20 seconds), with monolayers of adherent cells expressing either P 2X1wt or P 2X1del receptors using Fura-2 (this study), parallels those studies (after adjusting for x-axis differences) using platelet suspensions using the Fura-2 indicator. 21, 22, 25, 26 As discussed in "Materials and methods," Ca ϩϩ influx measured using Fura-2 results in fluorescence signals summarized from the activation of a population of adherent cells, not an individual cell. In contrast, the electrophysiological technique is capable of extremely rapid millisecond measurements 29 of extremely rapid (20 msec) activation. 22, 43 Another alternative method-for example, the nystatinpermeabilized patch technique, records subsecond Ca ϩϩ fluxes of individual platelets. 22, 43 Pharmacologic evidence indicates that platelets express several types of nucleotide receptors. The P 2Y1 (or the P2T PLC ) receptor is coupled to G q proteins, activates Ca ϩϩ mobilization, and mediates platelet shape change and aggregation. [10] [11] [12] The involvement of the P 2Y1 receptor and the pathway involving the G q protein in ADP-induced platelet activation was investigated using knockout mice for the P 2Y1 receptor and the G ␣q subunit. [17] [18] [19] [20] The recently identified P2Y 12 G i -linked receptor is coupled to the inhibition of adenylyl cyclase and is a target for the antithrombotic reagents ticlopidine, clopidogrel, and AR-C69096. 13 It should be noted that the determination of cytosolic Ca ϩϩ levels in experiments 17, 19, 20 are all conducted in the presence of EDTA, which would completely block any contribution of Ca ϩϩ influx to the Fura-2 or Indo-1 signals. Under these conditions, only Ca ϩϩ mobilization, not ADP-activated Ca ϩϩ influx, would be observed. The involvement of the ADP-activated calcium influx channel to the activation of platelets remains under investigation, but several reports (this study and 21, 25 ) have shown that ADP is an agonist at P 2X1wt receptors in contrast to other findings. 31 We propose that previous reports of P 2X1 receptors on platelets 21, 22, [24] [25] [26] have actually been recognizing both the P 2X1wt receptor and the P 2X1del receptor identified in this report: (1) the P 2X1wt (399 amino acids) and P 2X1del (382 amino acids) receptors in glycosylated form have identical electrophoretic mobilities and are not distinguishable by Western blotting or immunoprecipitation techniques using surface-biotinylated native megakaryocytic cell lines or transfected cells containing P 2X1wt or P 2X1del receptors; and (2) the available anti-P 2X1 receptor antibodies target amino acid sequences that are common to both receptor forms and, therefore, fail to differentiate between the P 2X1wt and P 2X1del receptors. In the literature, slight size differences between P 2X1wt receptors and cross-reactive proteins have been previously noted. 21, 24 Specifically, an antibody recognizing a 60-kd P 2X1 receptor with transiently transfected 293T cells cross-reacts with a more abundant smaller protein of 55 to 57 kd in purified human platelets. 24 Similarly, the rat vas deferens P 2X1wt receptor is larger than the cross-reactive human platelet protein, even though the rat and the human P 2X1 receptors have identical (399-amino acid) ORFs. We hypothesize that in both of these reports, the smaller protein recognized by the anti-P 2X1 antibody is the P 2X1del receptor identified in the current study.
In summary, the current study shows that stable expression of the P 2X1del receptor in 1321 cells confers a preferential activation by ADP resulting in Ca ϩϩ influx and that this receptor is expressed in megakaryocytic cell lines and platelets and may be involved in ADP-induced platelet activation.
